Editors' Note: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. Lewis A, Galetta S. Neurology 2022;98:470.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lewis A, Galetta S. Editors' Note: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. Neurology 2022;98:470.
PMID: 35288474